136 related articles for article (PubMed ID: 7932104)
21. Determination of erythrocyte methotrexate polyglutamates by liquid chromatography/tandem mass spectrometry after low-dose methotrexate therapy in Chinese patients with rheumatoid arthritis.
Mo X; Wen Y; Ren B; Chen J; Xu C; Wang X; Huang M; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():41-8. PubMed ID: 22999476
[TBL] [Abstract][Full Text] [Related]
22. HPLC determination of erythrocyte methotrexate polyglutamates after low-dose methotrexate therapy in patients with rheumatoid arthritis.
Dervieux T; Orentas Lein D; Marcelletti J; Pischel K; Smith K; Walsh M; Richerson R
Clin Chem; 2003 Oct; 49(10):1632-41. PubMed ID: 14500588
[TBL] [Abstract][Full Text] [Related]
23. High-performance liquid chromatographic analysis of MTX, 7-OH-MTX and MTX derivatives: application to intracellular metabolism in tumor cells (HT 29).
Durand R; Fabre G; Cano JP; Catalin J; Ahmed OA; Just S
J Appl Toxicol; 1983 Aug; 3(4):189-95. PubMed ID: 6196390
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous quantitation of methotrexate and its two main metabolites in biological fluids by a novel solid-phase extraction procedure using high-performance liquid chromatography.
Albertioni F; Pettersson B; Beck O; Rask C; Seideman P; Peterson C
J Chromatogr B Biomed Appl; 1995 Mar; 665(1):163-70. PubMed ID: 7795788
[TBL] [Abstract][Full Text] [Related]
25. HPLC determination of methotrexate and its metabolite in serum.
Brandsteterová E; Seresová O; Miertus S; Reichelová V
Neoplasma; 1990; 37(4):395-403. PubMed ID: 2234201
[TBL] [Abstract][Full Text] [Related]
26. Renal and hepatic toxicity after high-dose 7-hydroxymethotrexate in the rat.
Smeland E; Bremnes RM; Andersen A; Jaeger R; Eide TJ; Huseby NE; Aarbakke J
Cancer Chemother Pharmacol; 1994; 34(2):119-24. PubMed ID: 8194163
[TBL] [Abstract][Full Text] [Related]
27. Liquid-liquid extraction in the 96-well plate format with SRM LC/MS quantitative determination of methotrexate and its major metabolite in human plasma.
Steinborner S; Henion J
Anal Chem; 1999 Jul; 71(13):2340-5. PubMed ID: 10405602
[TBL] [Abstract][Full Text] [Related]
28. Highly sensitive high-performance liquid chromatographic assay for methotrexate in the presence and absence of anti-methotrexate antibody fragments in rat and mouse plasma.
Lobo ED; Balthasar JP
J Chromatogr B Biomed Sci Appl; 1999 Dec; 736(1-2):191-9. PubMed ID: 10676999
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in plasma and bone marrow of children receiving low-dose oral methotrexate.
Sonneveld P; Schultz FW; Nooter K; Hählen K
Cancer Chemother Pharmacol; 1986; 18(2):111-6. PubMed ID: 3791556
[TBL] [Abstract][Full Text] [Related]
30. High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate.
Chládková J; Hak J; Martínková J; Chládek J
Arzneimittelforschung; 2010; 60(12):769-75. PubMed ID: 21265469
[TBL] [Abstract][Full Text] [Related]
31. Simple and reliable HPLC method for the monitoring of methotrexate in osteosarcoma patients.
Begas E; Papandreou C; Tsakalof A; Daliani D; Papatsibas G; Asprodini E
J Chromatogr Sci; 2014 Aug; 52(7):590-5. PubMed ID: 23800772
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate.
Breithaupt H; Küenzlen E
Cancer Treat Rep; 1982 Sep; 66(9):1733-41. PubMed ID: 6956440
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of methotrexate (MTX) and 7-hydroxymethotrexate (7-OH-MTX) in rats and evidence for the metabolism of MTX to 7-OH-MTX.
Fahrig L; Brasch H; Iven H
Cancer Chemother Pharmacol; 1989; 23(3):156-60. PubMed ID: 2924373
[TBL] [Abstract][Full Text] [Related]
34. Determination of methotrexate and its metabolite 7-hydroxymethotrexate by direct injection of human plasma into a column-switching liquid chromatographic system using post-column photochemical reaction with fluorimetric detection.
Yu Z; Westerlund D; Boos KS
J Chromatogr B Biomed Sci Appl; 1997 Feb; 689(2):379-86. PubMed ID: 9080325
[TBL] [Abstract][Full Text] [Related]
35. Development of an Assay for Methotrexate and Its Metabolites 7-Hydroxy Methotrexate and DAMPA in Serum by LC-MS/MS.
Schofield RC; Ramanathan LV; Murata K; Fleisher M; Pessin MS; Carlow DC
Methods Mol Biol; 2016; 1383():213-22. PubMed ID: 26660190
[TBL] [Abstract][Full Text] [Related]
36. Analysis of methotrexate and 7-hydroxymethotrexate by high-pressure liquid chromatography.
Wisnicki JL; Tong WP; Ludlum DB
Cancer Treat Rep; 1978 Apr; 62(4):529-32. PubMed ID: 657149
[TBL] [Abstract][Full Text] [Related]
37. Plasma kinetic study of folinic acid and 5-methyltetrahydrofolate in healthy volunteers and cancer patients by high-performance liquid chromatography.
Payet B; Fabre G; Tubiana N; Cano JP
Cancer Chemother Pharmacol; 1987; 19(4):319-25. PubMed ID: 3496173
[TBL] [Abstract][Full Text] [Related]
38. High-performance liquid chromatographic assay of methotrexate, 7-hydroxymethortrexate, 4-deoxy-4-amino-N10-methylpteroic acid and sulfamethoxazole in serum, urine and cerebrospinal fluid.
Cairnes DA; Evans WE
J Chromatogr; 1982 Aug; 231(1):103-10. PubMed ID: 7119052
[TBL] [Abstract][Full Text] [Related]
39. A specific HPLC assay to determine the pharmacokinetics of methotrexate in patients.
Chen ML; McGuire WP; Lad TE; Chiou WL
Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):1-6. PubMed ID: 6698654
[TBL] [Abstract][Full Text] [Related]
40. Theoretically required urinary flow during high-dose methotrexate infusion.
Sasaki K; Tanaka J; Fujimoto T
Cancer Chemother Pharmacol; 1984; 13(1):9-13. PubMed ID: 6733846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
